Oncorus, Inc.
50 Hampshire Street, Suite 401
Cambridge, Massachusetts 02139
November 10, 2021
Via EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jordan Nimitz
Re: Oncorus, Inc.
Registration Statement on Form S-3 (File No. 333-260718)
Request for Acceleration of Effective Date
Ladies & Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-260718) (the “Registration Statement”), to become effective on November 12, 2021, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Marc Recht of Cooley LLP, counsel to the Registrant, at (617) 937-2316, or in his absence, Courtney T. Thorne at (617) 937-2318.
| Very truly yours, | ||
| Oncorus, Inc. | ||
| By: | /s/ Ted Ashburn | |
| Theodore (Ted) Ashburn, M.D., Ph.D. | ||
| President and Chief Executive Officer | ||
cc:
John McCabe, Oncorus, Inc.
Brian Shea, Oncorus, Inc.
Marc Recht, Cooley LLP
Brian Leaf, Cooley LLP
Daniel Goldberg, Cooley LLP
Courtney Thorne, Cooley LLP
